Search

Your search keyword '"Meier, W."' showing total 56 results
Start Over Author "Meier, W." Publisher georg thieme verlag kg
56 results on '"Meier, W."'

1. Importance of pelvic Lymphonodectomy in Squamous Cell Carcinoma of the Vulva (VSCC) Subgroup Analysis of the AGO-CaRE-1 Study

Author

Jueckstock, J., Fuerst, S., Bommert, M., Harter, P., Prieske, K., Eulenburg, C., Hilpert, F., deGregorio, N., Iborra, S., Sehouli, J., Ignatov, A., Hillemanns, P., Jaeger, A., Strauss, H-G, Baumann, K., Thiel, F., Mustea, A., Meier, W., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Woelber, L., Mahner, S., Jueckstock, J., Fuerst, S., Bommert, M., Harter, P., Prieske, K., Eulenburg, C., Hilpert, F., deGregorio, N., Iborra, S., Sehouli, J., Ignatov, A., Hillemanns, P., Jaeger, A., Strauss, H-G, Baumann, K., Thiel, F., Mustea, A., Meier, W., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Woelber, L., and Mahner, S.

Published
2020

2. The influence of age on treatment and prognosis of patients with squamous cell vulvar cancer (VSCC)- a subset analysis of the AGO-CaRE-1 study

Author

Prieske, K., Woelber, L., Muallem, M. Z., Eulenburg, C., Jueckstock, J., Hilpert, F., de Gregorio, N., Iborra, S., Ignatov, A., Hillemanns, P., Fuerst, S. T., Strauss, H. G., Baumann, K., Thiel, F., Mustea, A., Meier, W., Harter, P., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Sehouli, J., Mahner, S., Prieske, K., Woelber, L., Muallem, M. Z., Eulenburg, C., Jueckstock, J., Hilpert, F., de Gregorio, N., Iborra, S., Ignatov, A., Hillemanns, P., Fuerst, S. T., Strauss, H. G., Baumann, K., Thiel, F., Mustea, A., Meier, W., Harter, P., Wimberger, P., Hanker, L., Schmalfeldt, B., Canzler, U., Fehm, T., Luyten, A., Hellriegel, M., Kosse, J., Heiss, C., Hantschmann, P., Mallmann, P., Tanner, B., Pfisterer, J., Sehouli, J., and Mahner, S.

Published
2020

3. Bedeutung der pelvinen Lymphonodektomie beim Plattenepithelkarzinom der Vulva (VSCC) – Subgruppenanalyse der AGO-CaRE-1 Studie

Author

Jueckstock, J, additional, Fuerst, S, additional, Bommert, M, additional, Harter, P, additional, Prieske, K, additional, Eulenburg, C, additional, Hilpert, F, additional, deGregorio, N, additional, Iborra, S, additional, Sehouli, J, additional, Ignatov, A, additional, Hillemanns, P, additional, Jaeger, A, additional, Strauss, H-G, additional, Baumann, K, additional, Thiel, F, additional, Mustea, A, additional, Meier, W, additional, Wimberger, P, additional, Hanker, L, additional, Schmalfeldt, B, additional, Canzler, U, additional, Fehm, T, additional, Luyten, A, additional, Hellriegel, M, additional, Kosse, J, additional, Heiss, C, additional, Hantschmann, P, additional, Mallmann, P, additional, Tanner, B, additional, Pfisterer, J, additional, Woelber, L, additional, and Mahner, S, additional

Published
2020
Full Text
View/download PDF

4. Carboplatin/Caelyx/Bevacizumab vs. Carboplatin/Gemcitabine/Bevacizumab beim platinsensiblen Ovarialkarzinomrezidiv: Ergebnisse der prospektiv-randomisierten Phase III AGO-OVAR 2.21 Studie

Author

de Gregorio, N, additional, Park-Simon, TW, additional, Meier, W, additional, Kommoss, S, additional, Hilpert, F, additional, Lück, HJ, additional, Baumann, K, additional, Harter, P, additional, Sehouli, J, additional, Canzler, U, additional, Schmalfeldt, B, additional, Hein, A, additional, Hanker, L, additional, Marmé, F, additional, El-Balat, A, additional, Mahner, S, additional, Kimmig, R, additional, Burges, A, additional, Schröder, W, additional, Jackisch, C, additional, Gropp-Meier, M, additional, Fehm, T, additional, Hasenburg, A, additional, Denschlag, D, additional, Belau, A, additional, and Pfisterer, J, additional

Published
2019
Full Text
View/download PDF

6. Lebensqualität unter Niraparib-Erhaltungstherapie bei Patientinnen mit rezidiviertem Ovarialkarzinom: Ergebnisse der AGO-OVAR 2.22-Studie (ENGOT-OV16/NOVA)

Author

Trillsch, F, additional, du Bois, A, additional, Sehouli, J, additional, Canzler, U, additional, Marmé, F, additional, Hilpert, F, additional, Lück, HJ, additional, Meier, W, additional, Emons, G, additional, Heubner, ML, additional, Harter, P, additional, Reinthaller, A, additional, Mirza, MR, additional, Oza, A, additional, and Mahner, S, additional

Published
2018
Full Text
View/download PDF

7. Sicherheit und Wirksamkeit von Niraparib bei älteren Patientinnen mit rezidiviertem Ovarialkarzinom: eine Subgruppenanalyse der AGO Ovar 2.22 (ENGOT-OV16/NOVA) Phase III Studie

Author

Marmé, F, additional, du Bois, A, additional, Sehouli, J, additional, Canzler, U, additional, Hilpert, F, additional, Lück, HJ, additional, Meier, W, additional, Emons, G, additional, Heubner, ML, additional, Wölber, L, additional, Harter, P, additional, Marth, C, additional, Mirza, MR, additional, and Mahner, S, additional

Published
2018
Full Text
View/download PDF

8. Randomized controlled phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer – AGO DESKTOP III/ENGOT ov20

Author

Harter, P, additional, Sehouli, J, additional, Meier, W, additional, Reuss, A, additional, Hillemanns, P, additional, Hasenburg, A, additional, Reinthaller, A, additional, Hilpert, F, additional, Denschlag, D, additional, Burges, A, additional, Hanker, L, additional, Gropp-Meier, M, additional, Canzler, U, additional, Lampe, B, additional, Schutz, R, additional, and du Bois, A, additional

Published
2018
Full Text
View/download PDF

9. Sentinellymphonodektomie beim Vulvakarzinom: Eine Subgruppenanalye der AGO-CaRE-1 Multicenterstudie

Author

Klapdor, R, primary, Wölber, L, additional, Jückstock, J, additional, Hillemanns, P, additional, Hilpert, F, additional, de Gregorio, N, additional, Iborra, S, additional, Sehouli, J, additional, Habermann, A, additional, Fürst, ST, additional, Strauß, HG, additional, Baumann, K, additional, Thiel, F, additional, Mustea, A, additional, Meier, W, additional, Harter, P, additional, Wimberger, P, additional, Hanker, L, additional, Schmalfeldt, B, additional, Canzler, U, additional, Fehm, T, additional, Luyten, A, additional, Hellriegel, M, additional, Kosse, J, additional, Heiss, C, additional, Hantschmann, P, additional, Mallmann, P, additional, Tanner, B, additional, Pfisterer, J, additional, Richter, B, additional, Jäger, M, additional, and Mahner, S, additional

Published
2016
Full Text
View/download PDF

10. Incidence of germline mutations in risk genes including BRCA1/2 in consecutive ovarian cancer (OC) patients (AGO TR-1)

Author

Kommoss, S, primary, Harter, P, additional, Hauke, J, additional, Heitz, F, additional, Reuss, A, additional, Marmé, F, additional, Heimbach, A, additional, Prieske, K, additional, Richters, L, additional, Burges, A, additional, Neidhardt, G, additional, de Gregorio, N, additional, El-Balat, A, additional, Hilpert, F, additional, Meier, W, additional, Heubner, M, additional, Kast, K, additional, Braicu, I, additional, Hahnen, E, additional, and Schmutzler, R, additional

Published
2016
Full Text
View/download PDF

11. Prognose nach isoliertem Lokalrezidiv beim Vulvakarzinom – eine Subgruppenanalyse der AGO-CaRE-1 Studie

Author

Wölber, L, primary, Jückstock, J, additional, Neuser, P, additional, Hilpert, F, additional, de Gregorio, N, additional, Iborra, S, additional, Sehouli, J, additional, Habermann, A, additional, Hillemanns, P, additional, Fürst, S, additional, Strauss, HG, additional, Baumann, K, additional, Thiel, F, additional, Mustea, A, additional, Meier, W, additional, Harter, P, additional, Wimberger, P, additional, Hanker, L, additional, Schmalfeldt, B, additional, Canzler, U, additional, Fehm, T, additional, Luyten, A, additional, Hellrigel, M, additional, Kosse, J, additional, Heiss, C, additional, Hantschmann, P, additional, Mallmann, P, additional, Tanner, B, additional, Pfisterer, J, additional, Richter, B, additional, Eulenburg, C, additional, and Mahner, S, additional

Published
2016
Full Text
View/download PDF

12. Visual-Evoked Potentials in Long-Term Survivors of Acute Lymphoblastic Leukemia in Childhood

Author

Langer T, J D Beck, D Wenzel, H Hertzberg, M A Uberall, and Meier W

Subjects
medicine.medical_specialty, genetic structures, business.industry, Leukodystrophy, General Medicine, medicine.disease, Gastroenterology, Asymptomatic, Nerve conduction velocity, Surgery, Leukemia, El Niño, Internal medicine, Acute lymphocytic leukemia, Relative risk, Pediatrics, Perinatology and Child Health, medicine, Methotrexate, Neurology (clinical), medicine.symptom, business, medicine.drug
Abstract

Visual-evoked potentials (VEPs) were studied in 92 asymptomatic long-term survivors of acute lymphoblastic leukemia (ALL) in first complete remission 6-7 years after cessation of therapy in order to detect therapy-related disturbances in conduction velocity capacities within central nerve fibers. Subjects were grouped with respect to CNS prophylaxis: a) ith. MTX and 18 Gy cranial irradiation (group A, n = 58), b) ith. MTX and iv. MHD-MTX, no cranial irradiation (group B, n = 34). At follow-up VEPs were abnormal in 10 subjects (10.9 %) with comparable rates in both CNS prophylaxis groups (A: 7/58 [12.1 %], B: 3/34 [8.8 %]; p = 0.56). Participants with radiological signs of leukodystrophy (n = 14), all within the irradiated CNS prophylaxis group, showed significantly prolonged P100 latencies and had a 6.1-fold increased relative risk to develop VEP disturbances. No correlation could be established between VEP outcome and illness- or treatment-related parameters. VEP outcome was not correlated with age at diagnosis or gender. Thus, VEP recordings showed a close relationship with radiation-induced CNS white-matter disturbances. However, their value for clinical practice, routinely performed follow-up evaluations or standardized posttreatment surveillance studies is negligible.

Published
1996
Full Text
View/download PDF

13. Die AGO-OVAR 2.20/PENELOPE Studie – Therapie des platinresistenten Ovarialkarzinoms mit Pertuzumab (P) und Chemotherapie (CT) nach Biomarker-unterstützter Präselektion von Patienten

Author

Kurzeder, C, primary, Schmalfeldt, B, additional, Grischke, EM, additional, Rau, J, additional, Meier, W, additional, Lück, HJ, additional, Hasenburg, A, additional, Belau, A, additional, Mahner, S, additional, Marmé, F, additional, Hilpert, F, additional, Gropp-Meier, M, additional, Zorr, A, additional, Vergote, I, additional, Hils, R, additional, Canzler, U, additional, Rein, D, additional, de Gregorio, N, additional, Jackisch, C, additional, Gerber, B, additional, and du Bois, A, additional

Published
2014
Full Text
View/download PDF

14. Erhaltungstherapie mit Olaparib nach platinhaltiger Re-induktion bei platinsensitivem serösem Ovarialkarzinomrezidiv: eine Placebo-kontrollierte Phase II Studie

Author

Harter, P, primary, du Bois, A, additional, WImberger, P, additional, Schmalfeldt, B, additional, Emons, G, additional, Kreienberg, R, additional, Hilpert, F, additional, Lück, HJ, additional, Matulonis, U, additional, Gourley, C, additional, Friedlander, M, additional, Vergote, I, additional, Rustin, G, additional, Scott, C, additional, Meier, W, additional, Shapira-Frommer, R, additional, Safra, T, additional, Matei, D, additional, Fielding, A, additional, Mapherson, E, additional, Dougherty, B, additional, Juergensmeier, JM, additional, Orr, M, additional, and Ledermann, J, additional

Published
2014
Full Text
View/download PDF

15. Prognostische Bedeutung von Zeitintervall und Staging-Prozeduren für Patientinnen mit primären Borderline-Tumoren des Ovars (BOT): Eine Subgruppen-Analyse der Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) ROBOT-Studie

Author

Trillsch, F, primary, Mahner, S, additional, Woelber, L, additional, Vettorazzi, E, additional, Reuss, A, additional, Baumann, K, additional, Keyver-Paik, MD, additional, Canzler, U, additional, Wollschlaeger, K, additional, Forner, D, additional, Pfisterer, J, additional, Schroeder, W, additional, Muenstedt, K, additional, Richter, B, additional, Fotopoulou, C, additional, Schmalfeldt, B, additional, Burges, A, additional, Ewald-Riegler, N, additional, De Gregorio, N, additional, Hilpert, F, additional, Fehm, T, additional, Meier, W, additional, Hillemanns, P, additional, Hanker, L, additional, Hasenburg, A, additional, Strauß, HG, additional, Hellriegel, M, additional, Wimberger, P, additional, and du Bois, A, additional

Published
2014
Full Text
View/download PDF

16. Unabhängige Analyse der AGO-OVAR 12, einer GCIG/ENGOT-Intergroup Phase III Studie mit Nintedanib in der Firstline Therapie beim Ovarialkarzinom

Author

Mahner, S, primary, Hilpert, F, additional, Meier, W, additional, Sailer, O, additional, Hanker, L, additional, Canzler, U, additional, Sehouli, J, additional, Baumann, K, additional, Burges, A, additional, Gropp, M, additional, Hasenburg, A, additional, Belau, A, additional, Fehm, T, additional, Kosse, J, additional, Schmalfeldt, B, additional, Marme, F, additional, Cibula, D, additional, Richter, B, additional, Herwig, U, additional, Liebrich, C, additional, Gerber, B, additional, Potenberg, J, additional, Krabisch, P, additional, Thill, M, additional, Harter, P, additional, Kimmig, R, additional, de Gregorio, N, additional, Pfisterer, J, additional, Merger, M, additional, and du Bois, A, additional

Published
2014
Full Text
View/download PDF

17. AGO-OVAR 12: Eine randomisierte, Placebo-kontrollierte Phase III-Studie zum Einsatz von Carboplatin und Paclitaxel ± Nintedanib beim fortgeschrittenen Ovarialkarzinom (GCIG/ENGOT-Intergroup-Studie)

Author

Canzler, U, primary, Hilpert, F, additional, Meier, W, additional, Reuß, A, additional, Hanker, LC, additional, Sehouli, J, additional, Baumann, K, additional, Burges, A, additional, Gropp-Meier, M, additional, Hasenburg, A, additional, Belau, A, additional, Fehm, T, additional, Kosse, J, additional, Mahner, S, additional, Schmalfeldt, B, additional, Marmé, F, additional, Richter, B, additional, Cibula, D, additional, Harter, P, additional, Kimmig, R, additional, de Gregorio, N, additional, Pfisterer, J, additional, Merger, M, additional, and du Bois, A, additional

Published
2014
Full Text
View/download PDF

18. Lokaler Resektionsrand und Rezidivrisiko beim Plattenepithelkarzinom der Vulva – Ergebnisse einer Subgruppenanalyse der multizentrischen AGO CaRE-1 Studie

Author

Woelber, L, primary, Kosse, J, additional, Heiss, C, additional, Neuser, P, additional, Hantschmann, P, additional, Mallmann, P, additional, Tanner, B, additional, Pfisterer, J, additional, Richter, B, additional, Jückstock, J, additional, Hilpert, F, additional, De Gregorio, N, additional, Iborra, S, additional, Sehouli, J, additional, Habermann, A, additional, Hillemanns, P, additional, Fürst, S, additional, Strauss, HG, additional, Baumann, K, additional, Thiel, F, additional, Mustea, A, additional, Meier, W, additional, Harter, P, additional, Wimberger, P, additional, Hanker, L, additional, Schmalfeldt, B, additional, Canzler, U, additional, Fehm, T, additional, Luyten, A, additional, Hellriegel, M, additional, and Mahner, S, additional

Published
2014
Full Text
View/download PDF

20. S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours

Author

Wagner, U., additional, Harter, P., additional, Hilpert, F., additional, Mahner, S., additional, Reuß, A., additional, du Bois, A., additional, Petru, E., additional, Meier, W., additional, Ortner, P., additional, König, K., additional, Lindel, K., additional, Grab, D., additional, Piso, P., additional, Ortmann, O., additional, Runnebaum, I., additional, Pfisterer, J., additional, Lüftner, D., additional, Frickhofen, N., additional, Grünwald, F., additional, Maier, B., additional, Diebold, J., additional, Hauptmann, S., additional, Kommoss, F., additional, Emons, G., additional, Radeleff, B., additional, Gebhardt, M., additional, Arnold, N., additional, Calaminus, G., additional, Weisse, I., additional, Weis, J., additional, Sehouli, J., additional, Fink, D., additional, Burges, A., additional, Hasenburg, A., additional, and Eggert, C., additional

Published
2013
Full Text
View/download PDF

21. Krankheitsverlauf von Patientinnen mit Borderline Tumoren des Ovars: Ergebnisse der multizentrischen AGO „ROBOT“ Studie

Author

Schmalfeldt, B, primary, Burges, A, additional, Hilpert, F, additional, Reuß, A, additional, Fehm, T, additional, Meier, W, additional, Kommoss, F, additional, Hillemanns, P, additional, Hanker, L, additional, Hasenburg, A, additional, Strauß, HG, additional, Hellriegel, M, additional, Wimberger, P, additional, Kommoss, S, additional, Ewald-Riegler, N, additional, de Gregorio, N, additional, Mahner, S, additional, Fotopoulou, C, additional, Hauptmann, S, additional, and du Bois, A, additional

Published
2012
Full Text
View/download PDF

29. Haematopoietic Transplant Potential of Unrelated and Related Cord Blood: The first six Years of the EUROCORD/NETCORD Bank Germany

Author

Kögler, G., primary, Somville, T., additional, Göbel, U., additional, Hakenberg, P., additional, Knipper, A., additional, Fischer, J., additional, Adams, O., additional, Krempe, C., additional, Mc Kenzie, C., additional, Rüttgers, H., additional, Meier, W., additional, Bellmann, O., additional, Streng, H., additional, Ring, A., additional, Rosseck, U., additional, Rocha, V., additional, and Wernet, P., additional

Published
1999
Full Text
View/download PDF

39. Der Einfluß der Aneurysmektomie auf die linksventrikuläre Funktion

Author

Wellauer J, Meier W, Lichtlen P, Krayenbühl Hp, Senning A, Schönbeck M, W. Rutishauser, and Müller M

Subjects
Ejection fraction, medicine.diagnostic_test, business.industry, Anterior wall, General Medicine, medicine.disease, Ventricular aneurysm, medicine.anatomical_structure, Aneurysm, Bypass surgery, Angiography, Medicine, business, Nuclear medicine, Right anterior, Artery
Abstract

The effect of successful aortocoronary artery bypass surgery on left ventricular (LV) function was studied by angiography in 13 patients with coronary-artery disease and resection of a ventricular aneurysm. The following were calculated from single-plane right anterior oblique LV cine-angiograms: LV end-diastolic volume (EDV), end-systolic volume (ESV), ejection fraction (EF), percentage shortening of the medial perpendicular short axis (deltaM), mean velocity shortening of the circumferential fibres (VCF). The changes in the five hemi-axes of the anterior LV wall, and five of the inferior wall were averaged to give a value for relative anterior wall motion (SMV) and inferior wall motion (SMH). Changes in apical motion (SMS) were calculated from the percentage changes in the base-to-apex axis. The following mean values (x plus or minus s) were obtained four months before and 11 months after aneurysmectomy: EDVI (ml/m2) 154 plus or minus 27 (126 plus or minus 23), ESVI (ml/m2) 107 plus or minus 28 (56 plus or minus 15), SVI (ML/M2) 46.5 plus or minus 12.7 (69.9 plus or minus 23.1), EF (%) 32.6 plus or minus 8.0 (54.6 plus or minus 12.0), SMV (%) 6.1 plus or minus 10.0 (25.0 plus or minus 13.4), SMH (%) 25.9 plus or minus 13.1 (31.2 plus or minus 11.1), SMS (%) 5.1 PLus or minus 3.4 (13.1 plus or minus 4.2). These results indicated significant improvement in ventricular pumping action and wall motion after aneurysm resection and aortacoronary bypass surgery in patients with coronary-artery disease and severe cardiac failure.

Published
1975
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results